Applicant, as named in the Orange Book

Agios Pharms Inc

Next listed expiry: Aqvesme on 31 Jul 2041. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Aqvesme mitapivat sulfate	mitapivat sulfate	216196	31 Jul 2041	patent, carve-out possible
Pyrukynd · 3 strengths mitapivat sulfate	mitapivat sulfate	216196	31 Jul 2041	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.